{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:46:27Z","timestamp":1785757587840,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":44,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013003","name":"University of Cagliari","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.msard.2026.107049","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:54:31Z","timestamp":1770047671000},"page":"107049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reduced retinal neuronal injury as a consequence of high efficacy DMT treatment: an OCT study"],"prefix":"10.1016","volume":"108","author":[{"given":"Antonio Francesco","family":"Vacca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Idini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Coghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Fronza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Lorefice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Cordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9068-9144","authenticated-orcid":false,"given":"Jessica","family":"Frau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2026.107049_bib0014","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/WNO.0000000000000057","article-title":"Retinal nerve fiber layer thickness, brain atrophy, and disability in multiple sclerosis patients","volume":"34","author":"Abalo-Lojo","year":"2014","journal-title":"J. Neuroophthalmol."},{"issue":"2","key":"10.1016\/j.msard.2026.107049_bib0022","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1212\/WNL.0000000000012125","article-title":"APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies","volume":"97","author":"Aytulun","year":"2021","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2026.107049_bib0013","article-title":"Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis","volume":"6","author":"Bsteh","year":"2020","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"6","key":"10.1016\/j.msard.2026.107049_bib0028","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1212\/WNL.0000000000003582","article-title":"Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: a retrospective study","volume":"88","author":"Button","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2026.107049_bib0016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/WNO.0000000000000802","article-title":"Long-term stability of neuroaxonal structure in Alemtuzumab-treated relapsing-remitting multiple sclerosis patients","volume":"40","author":"Chan","year":"2020","journal-title":"J. Neuroophthalmol."},{"issue":"2","key":"10.1016\/j.msard.2026.107049_bib0005","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1212\/NXI.0000000000000533","article-title":"pRNFL as a marker of disability worsening in the medium\/long term in patients with MS","volume":"6","author":"Cordano","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.msard.2026.107049_bib0012","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ana.25933","article-title":"Retinal INL thickness in multiple sclerosis: a mere marker of neurodegeneration?","volume":"89","author":"Cordano","year":"2021","journal-title":"Ann. Neurol."},{"issue":"15","key":"10.1016\/j.msard.2026.107049_bib0008","doi-asserted-by":"crossref","first-page":"e1685","DOI":"10.1212\/WNL.0000000000200977","article-title":"Differences in age-related retinal and cortical atrophy rates in multiple sclerosis","volume":"99","author":"Cordano","year":"2022","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2026.107049_bib0009","article-title":"Synaptic injury in the inner plexiform layer of the retina is associated with progression in multiple sclerosis","volume":"5","author":"Cordano","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"2","key":"10.1016\/j.msard.2026.107049_bib0019","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10072-020-04802-x","article-title":"Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod","volume":"42","author":"D'Ambrosio","year":"2021","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2026.107049_bib0026","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.msard.2026.107049_bib0027","doi-asserted-by":"crossref","first-page":"e1854","DOI":"10.1212\/WNL.0000000000010376","article-title":"Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension","volume":"95","author":"Hauser","year":"2020","journal-title":"Neurology"},{"issue":"5035","key":"10.1016\/j.msard.2026.107049_bib0001","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1126\/science.1957169","article-title":"Optical coherence tomography","volume":"254","author":"Huang","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.msard.2026.107049_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117552","article-title":"Clinical effects associated with five-year retinal nerve fiber layer thinning in multiple sclerosis","volume":"427","author":"Jakimovski","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107049_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120552","article-title":"A prospective study of disease modifying therapy and retinal atrophy in relapsing-remitting multiple sclerosis","volume":"446","author":"Kabanovski","year":"2023","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.msard.2026.107049_bib0011","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1093\/brain\/aww219","article-title":"Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis","volume":"139","author":"Knier","year":"2016","journal-title":"Brain"},{"issue":"20","key":"10.1016\/j.msard.2026.107049_bib0017","doi-asserted-by":"crossref","first-page":"e2525","DOI":"10.1212\/WNL.0000000000011933","article-title":"Modulation of retinal atrophy with Rituximab in multiple sclerosis","volume":"96","author":"Lambe","year":"2021","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2026.107049_bib0024","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1600-0404.2011.01622.x","article-title":"Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study","volume":"126","author":"Lanzillo","year":"2012","journal-title":"Acta Neurol. Scand."},{"issue":"6","key":"10.1016\/j.msard.2026.107049_bib0004","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S1474-4422(16)00068-5","article-title":"Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study","volume":"15","author":"Martinez-Lapiscina","year":"2016","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.msard.2026.107049_bib0030","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1007\/s00415-022-11183-y","article-title":"Retinal inner nuclear layer thinning is decreased and associates with the clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis","volume":"269","author":"Miscioscia","year":"2022","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2026.107049_bib0018","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/bcpt.13381","article-title":"Macular oedema and changes in macular thickness in multiple sclerosis patients treated with fingolimod","volume":"126","author":"N\u00f8rgaard","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.msard.2026.107049_bib0007","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/WNO.0000000000000768","article-title":"Macular ganglion cell and inner plexiform layer thickness is more strongly associated with visual function in multiple sclerosis than bruch membrane opening-minimum rim width or peripapillary retinal nerve fiber layer thicknesses","volume":"39","author":"Nguyen","year":"2019","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.msard.2026.107049_bib0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10354-022-00925-2","article-title":"Retinal imaging with optical coherence tomography in multiple sclerosis: novel aspects","volume":"172","author":"Olbert","year":"2022","journal-title":"Wien Med. Wochenschr."},{"issue":"10","key":"10.1016\/j.msard.2026.107049_bib0006","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","article-title":"Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis","volume":"16","author":"Petzold","year":"2017","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.msard.2026.107049_bib0003","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1474-4422(22)00200-9","article-title":"Diagnosis and classification of optic neuritis","volume":"21","author":"Petzold","year":"2022","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.msard.2026.107049_bib0025","article-title":"Natalizumab for relapsing remitting multiple sclerosis","author":"Pucci","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.msard.2026.107049_bib0023","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamaneurol.2013.573","article-title":"Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis","volume":"70","author":"Saidha","year":"2013","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.msard.2026.107049_bib0002","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.24487","article-title":"Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study","volume":"78","author":"Saidha","year":"2015","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2026.107049_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034823","article-title":"The OSCAR-IB consensus criteria for retinal OCT quality assessment","volume":"7","author":"Tewarie","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.msard.2026.107049_bib0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:03:53Z","timestamp":1785755033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826000854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":30,"alternative-id":["S2211034826000854"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107049","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced retinal neuronal injury as a consequence of high efficacy DMT treatment: an OCT study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107049"}}